April 30, 2024
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
April 29, 2024
Avram Miller Talks About Renovaro And Its Impact In Diagnosing Cancers and Infectious Diseases With AI
The potential impact of AI on healthcare is vast and transformative. With the use of AI platforms for diagnosing diseases like cancer, we can expect improved accuracy, efficiency, and outcomes in patient care. Renovaro stands at the forefront of this innovative shift towards a more intelligent healthcare system powered by artificial intelligence.
April 24, 2024
RenovaroCube to Acquire 100% Ownership of Cyclomics
RenovaroCube has entered into an amendment to its binding letter of intent to acquire 100% ownership of Cyclomics, further cementing their shared commitment to advancing state-of-the-art technologies in cancer diagnostics and treatment.
April 18, 2024
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board
This pivotal move signifies a major leap forward in Renovaro’s quest to redefine cancer diagnosis and treatment through cutting-edge AI and immunotherapy technologies.
February 14, 2024
Statement of Renovaro Inc
We felt compelled to comment on the shorter Hindenburg’s opinion piece.
February 13, 2024
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces.
A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing.
February 13, 2024
AI Pioneer GEDiCube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
“We believe this combination marks a significant milestone in the journey of personalized medicine,”
September 29, 2023
GEDiCube (Renovaro Cube) and Renovaro Biosciences Combine
GEDiCube/Renovaro Cube and Renovaro Biosciences Sign a Definitive Agreement to Combine
August 30, 2023
Renovaro Cube joins NVIDIA Inception
Renovaro Cube joins NVIDIA Inception to advance unique platform for early cancer detection in clinical trials
August 9, 2023
Announcing Intent to Merge
AI Company GEDi Cube International and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer